PSM Technical Briefing Seminar: Day One report

1. PSM Technical Briefing Seminar: Day One report • From 3 by 5 to Universal Access • Information flow key for programs involving chronic management: need for strategic information sharing on PSM at national level • Need to invest in the health care delivery systems • Opportunity to develop pharmaceutical sector • Build on existing capacity • HR: Task shifting training HR for additional responsibilities • Increasing lead times with increasing chances of wastage: need for companies to invest in increased production

2. PSM Technical Briefing Seminar: Day One report • From 3 by 5 to Universal access • Harmonization of country level PSM planning, budgeting and reporting • Universal access should address a package of continuum of care: prevention, treatment and care for all who need it. Countries could set own targets.

3. PSM Technical Briefing Seminar: Day One report • GDF – role in Universal access to TB treatment • Addressing increasing demand of raw materials for TB drugs • Need to support and encourage R&D for development of new molecules • NRAs have final say on what can be imported in the countries • Harmonization of management of consultants through audit reports

4. PSM Technical Briefing Seminar: Day One report • MMSS – role in Universal access to Malaria Rx • Short shelf life of ACTs • Quantification and Forecasting constraints • Controversial MoU between WHO and Novartis – to get low priced supplies of ACTs • Presence of only one pre-qualified supplier of ACTs • GF accepts procurement of products pre-qualified by WHO or any other stringent NRA in ICH/PICS countries • Issue of making ACTs available through private sector was discussed • Debate on the need for continued production of monotherapy artemisinin derivatives while shifting to ACTs • No sufficient data on safe use of ACTs in pregnancy- SP still use despite resistance

5. PSM Technical Briefing Seminar: Day One report • GFATM PSM Plan • Key principles: • transparent and competitive procurement • Best prices available • Follow international and national laws • Ensure product quality – WHO pre-qualified, ICH/PICS approved • PSM plans to be ready before grant signing • PSM plans can be reviewed as long the budget ceiling does not change • Countries are encouraged to include TA in their plans

6. PSM Technical Briefing Seminar: Day One report • Price Reporting Mechanisms • GF requires countries to report price and sources of products bought using GFATM funds • Prices of innovator medicines are publicly available unlike generics • Weak reporting from country level procurement to AMDS PRM • Plea: share PRM with clients but ask them to report to AMDS PRM • PRM currently only for ARVs

7. PSM Technical Briefing Seminar: Day One report • Supply Chain Management Systems • New partnership for SC mechanism for PEPFAR • It is a partnership made of profit and nonprofit NGOs and FBOs • Meant to augment and support existing system: Not compete • Wide consultation made and endorsed by many focus countries • Not meant to create parallel system but work with public, faith based and private commercial organizations

8. PSM Technical Briefing Seminar: Day One report • Happy Hour for the consultants – continued networking • Long, windy and freezing walk to Adina Apartment Hotels • Day one was done!

9. Thank you By Bannet & Sillo